Description
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.In VitroRovazolac is an anti-inflammatory drug candidate. MCE has not independently confirmed the accuracy of these methods. They are for reference only.IC50& Target:Target: LXR